Role of routine level III axillary lymph node dissection in breast cancer following neoadjuvant chemotherapy: A prospective observational study
European Journal of Cancer · 2026-03 · 237 · 116490
DOI: 10.1016/j.ejca.2026.116490 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2026-03. Verfasst von J.R. Vishnoi und 6 weiteren Autor:innen.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Vishnoi, J., Gulhane, A., Sharma, N., Poonia, D., Bhardwaj, M., Pareek, P., & Elhence, P. (2026). Role of routine level III axillary lymph node dissection in breast cancer following neoadjuvant chemotherapy: A prospective observational study. European Journal of Cancer, 237, 116490. https://doi.org/10.1016/j.ejca.2026.116490
Vancouver
Vishnoi J, Gulhane A, Sharma N, Poonia D, Bhardwaj M, Pareek P, et al. Role of routine level III axillary lymph node dissection in breast cancer following neoadjuvant chemotherapy: A prospective observational study. European Journal of Cancer. 2026;237:116490. doi:10.1016/j.ejca.2026.116490
BibTeX
@article{Vishnoi2026,
author = {Vishnoi, J.R. and Gulhane, A. and Sharma, N. and Poonia, D.R. and Bhardwaj, M. and Pareek, P. and Elhence, P.},
title = {Role of routine level III axillary lymph node dissection in breast cancer following neoadjuvant chemotherapy: A prospective observational study},
journal = {European Journal of Cancer},
year = {2026},
volume = {237},
pages = {116490},
doi = {10.1016/j.ejca.2026.116490}
}
EUVIMED